SC1
CAS No. 839707-37-8
SC1 ( Pluripotin )
Catalog No. M16118 CAS No. 839707-37-8
Pluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 39 | In Stock |
|
5MG | 55 | In Stock |
|
10MG | 77 | In Stock |
|
25MG | 135 | In Stock |
|
50MG | 208 | In Stock |
|
100MG | 332 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSC1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.
-
DescriptionPluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.
-
SynonymsPluripotin
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK1; RasGAP
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number839707-37-8
-
Formula Weight550.53
-
Molecular FormulaC27H25F3N8O2
-
Purity>98%(HPLC)
-
SolubilityEthanol: <1 mg/mL; DMSO: 100 mg/mL (181.64 mM) Water: <1 mg/mL
-
SMILESO=C(NC1=CC=C(C)C(N2CC3=CN=C(NC4=CC(C)=NN4C)N=C3N(C)C2=O)=C1)C5=CC=CC(C(F)(F)F)=C5
-
Chemical NameN-[3-[7-(2,5-Dimethyl-2H-pyrazol-3-ylamino)-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl]-4-methylphenyl]-3-trifluoromethyl-benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen S, et al. Proc natl Acad Sci U S A. 2006 Nov 14;103(46):17266-71.
molnova catalog
related products
-
KO-947
KO-947 is a potent and selective inhibitor of ERK1/2 kinase in biochemical, cellular and in vivo antitumor activity assays.
-
Astex ERK inhibitor ...
Astex ERK inhibitor X is a novel potent ERK1/2 inhibitor that inhibits ERK catalytic activity with IC50 of 3 nM in TRK kinase assays.
-
SMI-4a
TCS-PIM-1-4a, a Pim inhibitor, blocks mTORC1 activity through activation of AMPK and kills a wide range of both myeloid and lymphoid cell lines (IC50=0.8-40 μM).